NCT07422480: A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
- State
- Under way
- Phase
- Phase 3
- People
- 300 planned
- Started
- 21 May 2026
- Primary completion
- 30 Apr 2029
- Arms
- Elritercept
- Results
- None posted
- 20 Feb 2026: Trial registered
- 21 May 2026: Trial started